sibutramine has been researched along with Pregnancy in 11 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It is well established that sibutramine produces weight loss and is used frequently in women of childbearing age." | 7.76 | Sibutramine effects on the reproductive performance of pregnant overweight and non-overweight rats. ( Carnietto, N; Cicogna, AC; Fernandes, GS; Francia-Farje, LA; Kempinas, Wde G; Silva, DS; Volpato, GT, 2010) |
| "No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations." | 7.74 | Exposure to sibutramine during pregnancy. ( Garcia-Bournissen, F; Koren, G; Shrim, A, 2007) |
| "Sibutramine is a drug that is used in the treatment of obesity." | 7.73 | Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. ( Carducci, B; Caruso, A; Cavaliere, AF; De Santis, M; Straface, G, 2006) |
| "To our knowledge, this is the first report of sibutramine exposure in pregnancy." | 7.72 | Sibutramine use in pregnancy: report of two cases. ( Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F, 2004) |
| "It is well established that sibutramine produces weight loss and is used frequently in women of childbearing age." | 3.76 | Sibutramine effects on the reproductive performance of pregnant overweight and non-overweight rats. ( Carnietto, N; Cicogna, AC; Fernandes, GS; Francia-Farje, LA; Kempinas, Wde G; Silva, DS; Volpato, GT, 2010) |
| "No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations." | 3.74 | Exposure to sibutramine during pregnancy. ( Garcia-Bournissen, F; Koren, G; Shrim, A, 2007) |
| "Observational cohort studies were conducted using prescription-event monitoring (PEM) to examine the safety profiles of the anti-obesity agents orlistat and sibutramine." | 3.74 | The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England. ( Perrio, MJ; Shakir, SA; Wilton, LV, 2007) |
| "Sibutramine is a drug that is used in the treatment of obesity." | 3.73 | Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up. ( Carducci, B; Caruso, A; Cavaliere, AF; De Santis, M; Straface, G, 2006) |
| "To our knowledge, this is the first report of sibutramine exposure in pregnancy." | 3.72 | Sibutramine use in pregnancy: report of two cases. ( Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F, 2004) |
| "Weight loss during pregnancy is therefore considered a risk factor." | 1.38 | Appetite suppressants in pregnancy. ( Hubičková Heringová, L; Kralova, T; Manakova, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francia-Farje, LA | 1 |
| Silva, DS | 1 |
| Volpato, GT | 1 |
| Fernandes, GS | 1 |
| Carnietto, N | 1 |
| Cicogna, AC | 1 |
| Kempinas, Wde G | 1 |
| Manakova, E | 1 |
| Kralova, T | 1 |
| Hubičková Heringová, L | 1 |
| Connor, H | 1 |
| Annan, F | 1 |
| Bunn, E | 1 |
| Frost, G | 1 |
| McGough, N | 1 |
| Sarwar, T | 1 |
| Thomas, B | 1 |
| Hu, YH | 1 |
| Pang, DG | 1 |
| Qi, B | 1 |
| Lei, Q | 1 |
| You, S | 1 |
| Liu, YQ | 1 |
| Einarson, A | 1 |
| Bonari, L | 1 |
| Sarkar, M | 1 |
| McKenna, K | 1 |
| Koren, G | 2 |
| Kadioglu, M | 1 |
| Ulku, C | 1 |
| Yaris, F | 1 |
| Kesim, M | 1 |
| Kalyoncu, NI | 1 |
| Yaris, E | 1 |
| Mersebach, H | 1 |
| Klose, M | 1 |
| Svendsen, OL | 1 |
| Astrup, A | 1 |
| Feldt-Rasmussen, U | 1 |
| Ramzi, F | 1 |
| Elias, D | 1 |
| Mona, S | 1 |
| Zreik, TG | 1 |
| De Santis, M | 1 |
| Straface, G | 1 |
| Cavaliere, AF | 1 |
| Carducci, B | 1 |
| Caruso, A | 1 |
| Garcia-Bournissen, F | 1 |
| Shrim, A | 1 |
| Perrio, MJ | 1 |
| Wilton, LV | 1 |
| Shakir, SA | 1 |
11 other studies available for sibutramine and Pregnancy
| Article | Year |
|---|---|
Sibutramine effects on the reproductive performance of pregnant overweight and non-overweight rats.
Topics: Animals; Appetite Depressants; Cyclobutanes; Embryo Loss; Female; Overweight; Pregnancy; Rats; Rats, | 2010 |
Appetite suppressants in pregnancy.
Topics: Abnormalities, Multiple; Abortion, Spontaneous; Appetite Depressants; Cyclobutanes; Czech Republic; | 2012 |
The implementation of nutritional advice for people with diabetes.
Topics: Adolescent; Adult; Aged; Anti-Obesity Agents; Asian People; Body Composition; Child; Cyclobutanes; D | 2003 |
[Studies of the effects of sibutramine hydrochloride on perinatal development and maternal function in mice].
Topics: Animals; Behavior, Animal; Cyclobutanes; Female; Fetus; Male; Mice; Pregnancy; Pregnancy, Animal; Ra | 2004 |
Exposure to sibutramine during pregnancy: a case series.
Topics: Anti-Obesity Agents; Cyclobutanes; Female; Humans; Maternal Exposure; Obesity; Pregnancy; Pregnancy | 2004 |
Sibutramine use in pregnancy: report of two cases.
Topics: Adult; Antidepressive Agents; Cyclobutanes; Female; Follow-Up Studies; Humans; Infant, Newborn; Male | 2004 |
Combined dietary and pharmacological weight management in obese hypopituitary patients.
Topics: Adult; Anthropometry; Appetite Depressants; Blood Glucose; Body Composition; Cholesterol; Combined M | 2004 |
Sibutramine in pregnancy.
Topics: Adult; Appetite Depressants; Cyclobutanes; Female; Humans; Infant, Newborn; Male; Obesity; Pregnancy | 2005 |
Early first-trimester sibutramine exposure : pregnancy outcome and neonatal follow-up.
Topics: Abnormalities, Drug-Induced; Adult; Appetite Depressants; Body Mass Index; Counseling; Cyclobutanes; | 2006 |
Exposure to sibutramine during pregnancy.
Topics: Antidepressive Agents; Cohort Studies; Cyclobutanes; Female; Humans; Infant, Newborn; Pregnancy; Pre | 2007 |
The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; | 2007 |